PMC:7029759 / 19650-20537
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
419 | 47-56 | Species | denotes | 2019-nCoV | Tax:2697049 |
438 | 103-107 | Gene | denotes | ACE2 | Gene:59272 |
439 | 236-240 | Gene | denotes | ACE2 | Gene:59272 |
440 | 495-499 | Gene | denotes | ACE2 | Gene:59272 |
441 | 594-598 | Gene | denotes | scFv | Gene:652070 |
442 | 630-634 | Gene | denotes | ACE2 | Gene:59272 |
443 | 817-821 | Gene | denotes | ACE2 | Gene:59272 |
444 | 878-882 | Gene | denotes | ACE2 | Gene:59272 |
445 | 780-785 | Gene | denotes | spike | Gene:43740568 |
446 | 419-424 | Gene | denotes | spike | Gene:43740568 |
447 | 179-184 | Gene | denotes | spike | Gene:43740568 |
448 | 157-162 | Species | denotes | human | Tax:9606 |
449 | 215-226 | Species | denotes | coronavirus | Tax:11118 |
450 | 446-455 | Species | denotes | 2019-nCoV | Tax:2697049 |
451 | 693-704 | Species | denotes | coronavirus | Tax:11118 |
452 | 735-739 | Gene | denotes | ACE2 | Gene:59272 |
453 | 244-252 | Disease | denotes | infected | MESH:D007239 |
454 | 353-362 | Disease | denotes | infection | MESH:D007239 |
455 | 438-442 | Disease | denotes | SARS | MESH:D045169 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T735 | 12-18 | CHEBI:52217;CHEBI:52217 | denotes | agents |
T734 | 47-56 | SP_7 | denotes | 2019-nCoV |
T733 | 92-102 | GO:0010467 | denotes | expressing |
T732 | 103-107 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T731 | 116-120 | UBERON:0002048 | denotes | lung |
T730 | 125-141 | UBERON:0001555 | denotes | gastrointestinal |
T729 | 142-149 | UBERON:0000479 | denotes | tissues |
T728 | 157-162 | SP_6;NCBITaxon:9606 | denotes | human |
T727 | 200-207 | GO:0009986 | denotes | surface |
T726 | 215-226 | NCBITaxon:11118 | denotes | coronavirus |
T725 | 236-240 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T724 | 271-281 | GO:0035376 | denotes | cell entry |
T723 | 399-405 | SO:0000417 | denotes | domain |
T722 | 438-442 | SP_10 | denotes | SARS |
T721 | 446-455 | SP_7 | denotes | 2019-nCoV |
T720 | 495-499 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T719 | 550-558 | GO:0042571 | denotes | antibody |
T718 | 562-568 | SO:0000984 | denotes | single |
T717 | 575-583 | GO:0042571 | denotes | antibody |
T716 | 630-634 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T715 | 693-704 | NCBITaxon:11118 | denotes | coronavirus |
T714 | 735-739 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T713 | 740-753 | GO:0005576 | denotes | extracellular |
T712 | 754-760 | SO:0000417 | denotes | domain |
T711 | 801-807 | SO:0000417 | denotes | domain |
T710 | 817-821 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T709 | 878-882 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T105 | 72-77 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T106 | 86-91 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T107 | 116-120 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T108 | 142-149 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
T109 | 157-167 | Body_part | denotes | human body | http://purl.org/sig/ont/fma/fma305853 |
T110 | 185-192 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T111 | 253-258 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T112 | 271-275 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T113 | 425-432 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T114 | 550-558 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T115 | 575-583 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T116 | 786-793 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T8 | 116-120 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T58 | 353-362 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T59 | 438-442 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T168 | 72-77 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T169 | 86-91 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T170 | 116-120 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T171 | 116-120 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T172 | 157-162 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T173 | 253-258 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T174 | 271-275 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T175 | 659-660 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T176 | 798-800 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T177 | 883-885 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T75 | 185-192 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T76 | 425-432 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T77 | 786-793 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T123 | 0-78 | Sentence | denotes | Therapeutic agents that could be used to block 2019-nCoV from infecting cells. |
T124 | 79-168 | Sentence | denotes | Target cells expressing ACE2 include lung and gastrointestinal tissues in the human body. |
T125 | 169-282 | Sentence | denotes | The large spike protein on the surface of the coronavirus binds to ACE2 on infected cells, leading to cell entry. |
T126 | 283-363 | Sentence | denotes | Three proposed strategies would block this interaction would abrogate infection. |
T127 | 364-531 | Sentence | denotes | In the first, the receptor-binding domain (RBD) of the spike protein from SARS or 2019-nCoV would be administered, thereby binding ACE2 and saturating available sites. |
T128 | 532-658 | Sentence | denotes | Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same. |
T129 | 659-794 | Sentence | denotes | A third strategy would target the coronavirus virions directly by using the ACE2 extracellular domain as bait to bind to spike protein. |
T130 | 795-887 | Sentence | denotes | An Fc domain fused to ACE2 would facilitate prolonged circulation of the biologic (ACE2-Fc). |